Janus Henderson Group’s Yarrow Bioscience YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.37M Buy
+283,341
New +$9.7M ﹤0.01% 932
2020
Q1
– Sell
-356
Closed -$5.94M – 1427
2019
Q4
$5.94M Sell
356
-38
-10% -$633K ﹤0.01% 1026
2019
Q3
$6.35M Sell
394
-8
-2% -$129K ﹤0.01% 1026
2019
Q2
$8.68M Sell
402
-3
-0.7% -$74.2K ﹤0.01% 967
2019
Q1
$11.4M Sell
405
-44
-10% -$1.06M 0.01% 896
2018
Q4
$6.66M Sell
449
-116
-21% -$2.6M ﹤0.01% 937
2018
Q3
$20M Sell
565
-1
-0.2% -$30.9K 0.01% 818
2018
Q2
$16.5M Sell
566
-2
-0.4% -$77.7K 0.01% 843
2018
Q1
$76.8M Buy
+568
New +$69.1M 0.05% 444

Other funds holding YARW

Janus Henderson Group's YARW Position: Q3 2026 in Review

Janus Henderson Group opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 283,341 shares worth $6.37M. The stake represents ﹤0.01% of the portfolio and ranks #932 among its holdings. This is a return to the name: Janus Henderson Group previously reported a position in YARW as recently as Q4 2019.

Janus Henderson Group first reported a position in YARW in Q1 2018 and has held it in 9 quarters since. The position peaked at $76.8M in Q1 2018. 50 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

  • Janus Henderson Group held 283,341 shares of Yarrow Bioscience worth $6.37M as of Q3 2026.
  • Yarrow Bioscience was a new Janus Henderson Group position in Q3 2026.
  • Yarrow Bioscience made up ﹤0.01% of Janus Henderson Group's portfolio in Q3 2026, its #932 holding.
  • Janus Henderson Group first reported a position in Yarrow Bioscience in Q1 2018 and has held it in 9 quarters since.
  • Janus Henderson Group's Yarrow Bioscience position peaked at $76.8M in Q1 2018.
  • 50 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.